Newswise — Languishing in the shadow of Alzheimer’s disease are a whole host of rarer dementias that are just as awful. Frontotemporal, Lewy body, and cerebrovascular disorders finally got a boost in attention when the National Institute of Neurological Disorders and Stroke hosted a summit on March 29 and 30. The meeting was a collective exercise to lay out what clinicians and scientists know about each of these diseases, and what the most fruitful research opportunities are at this point in time. The upshot of two days of talk and discussion? An updated National Plan and a beefed-up research budget—at least, that is the hope. If you want to know where science is heading on dementia with Lewy bodies, aphasia, mixed dementias, and more, read Alzforum’s two-part summary.

About UsFounded in 1996, Alzforum is a news and information resource website dedicated to helping researchers accelerate discovery and advance development of diagnostics and treatments for Alzheimer’s disease and related disorders.

Our site expands the traditional mode of scientific communication by reporting the latest scientific findings and industry news with insightful analysis that puts breaking news into context. We advance research by developing open-access databases of curated, highly specific scientific content to visualize and facilitate the exploration of complex data. Alzforum is a platform to disseminate the evolving knowledge around basic, translational, and clinical research in the field of AD.

Alzforum is supported by a team with backgrounds in science, journalism, information technology, design, and data science. Together with a distinguished Scientific Advisory Board, and the active participation of a global network of scientists, we strive to produce unbiased content to a rigorous editorial standard.

Alzforum is operated by the Biomedical Research Forum (BRF) LLC. BRF is a wholly owned subsidiary of FMR LLC. FMR LLC and its affiliates invest broadly in many companies, including life sciences and pharmaceutical companies. Alzforum does not endorse any specific product or scientific approach.